Extract notice to the Minister
Imbruvica
Common name / Subject : ibrutinib (LLC)
Name of the manufacturer : Janss. Inc
Form : Caps.
Dosage : 140 mg
Name of the manufacturer : Janss. Inc
Form : Caps.
Dosage : 140 mg
Indication : Leucémie lymphoïde chronique
INESSS' Recommendation
-
Minister's decisions
Inscrire aux listes des médicaments
Evaluation published on August 18, 2017